Actively Recruiting

Phase 1
Age: 18Years - 43Years
FEMALE
Healthy Volunteers
NCT05980091

Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.

Led by ART Fertility Clinics LLC · Updated on 2025-02-21

316

Participants Needed

2

Research Sites

118 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this study is to compare the difference in clinical pregnancy, miscarriage and livebirth rate between day 6 euploid blastocyst transfer on the 6th and the 7th day of progesterone exposure in Hormonal Replacement Therapy (HRT) FET cycles. This prospective \& randomized study will only include euploid day 6 blastocysts. This will be the first prospective study of euploid day 6 blastocysts thereby excluding aneuploidy as a cause of miscarriage and implantation failure. The point of randomization will occur on the day of progesterone commencement.

CONDITIONS

Official Title

Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.

Who Can Participate

Age: 18Years - 43Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 18 years to 43 years
  • Having at least 1 euploid cryopreserved day 6 blastocyst of at least Grade BB quality
  • Endometrial trilaminar appearance on the day of progesterone start
Not Eligible

You will not qualify if you...

  • Uterine abnormality
  • Hydrosalpinx
  • Asherman syndrome
  • Any known contraindications or allergy to oral estradiol or progesterone
  • Spontaneous ovulation during HRT cycle
  • Discontinuation of HRT medication

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

ART Fertility Clinics LLC

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates, 60202

Actively Recruiting

2

ART Fertility Clinics Dubai

Dubai, United Arab Emirates

Actively Recruiting

Loading map...

Research Team

B

Barbara Lawrenz, PhD

CONTACT

J

Jonalyn Edades, RN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration. | DecenTrialz